Product Reports Resources Pricing Login Book a demo

Generation Bio

Biotech & Life Sciences · Cambridge, United States · Founded 2016 · IPO 2020

Engages in developing genetic medicines through gene therapy platform for intrinsic hepatic diseases and systemic diseases

Revenue $20M

Investors

11 investors on Generation Bio's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 1 investor entered at this stage
Series B+ 10 investors entered at this stage
Transformation Capital
T. Rowe Price
Casdin Capital
Deerfield
Wellington Management
Fidelity Investments
Invus
Foresite Capital
National Institutes of Health
Farallon Capital Management

Global footprint

Where Generation Bio has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States98.2%
🇮🇳 India1.2%
🇨🇦 Canada1%
3 countries shown
Web traffic by country
2.5K monthly visits
across markets
🇺🇸 United States72%
🇮🇳 India32%
Top 2 markets shown

Talent graph

The shape of Generation Bio's talent

Dealroom maps Generation Bio's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Generation Bio's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$16M patent portfolio · 48 active families

Estimated portfolio value
$16M
20.9× smaller than top peer Translate Bio ($336M)
48 active patent families
Where Generation Bio innovates BiochemistryCapsidCellCell biologyMolecular biology

Where Generation Bio concentrates vs peers

Each axis is a top-10 topic across Generation Bio and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Generation Bio

An AI-synthesized read of the highest-engagement posts about Generation Bio on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Generation Bio on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.